We found levels of AFAP1-AS1 expression were markedly associated with retinoblastoma patients’ overall survival, as retinoblastoma patients with AFAP1-AS1 high-expression had shorter survival than those with AFAP1-AS1 low-expression (P<0.001, Figure 2). The gene discussed is AFAP1; the disease is retinoblastoma.